S&P 500
735.45
+0.33%
DOW
512.23
-0.40%
NASDAQ
656.09
+1.40%
Russell
273.76
+1.03%
VIX
22.89
-3.05%
FTSE
47.23
-1.38%
Nikkei
88.24
-0.02%
BTC
75,875.74
-0.56%
ETH
2,230.98
-0.93%
Gold
372.61
-0.77%
Oil
148.50
+0.20%
Silver
46.84
-0.19%
S&P 500
735.45
+0.33%
DOW
512.23
-0.40%
NASDAQ
656.09
+1.40%
Russell
273.76
+1.03%
VIX
22.89
-3.05%
FTSE
47.23
-1.38%
Nikkei
88.24
-0.02%
BTC
75,875.74
-0.56%
ETH
2,230.98
-0.93%
Gold
372.61
-0.77%
Oil
148.50
+0.20%
Silver
46.84
-0.19%
Stock
Ti
News
Markets
Stocks
Screener
Calendar
Watchlist
Loading...
Home
/
Stocks
/
TVRD
/
News
TVRD
NASDAQ · Pharmaceuticals
Tvardi Therapeutics Inc
Penny Stocks
Pharmaceutical Stocks
Healthcare Stocks
$0.96
+0.09 (+10.79%)
☆ Watch
As of Nov 7, 2:40 AM ET ·
Overview
Earnings
Forecast
Financials
News
Peers
TVRD News
1 articles
Tvardi Therapeutics Surges 40% on Promising Phase 1 Data for TTI-109
Tvardi Therapeutics shares surged 40% after Phase 1 data for TTI-109 showed rapid conversion and improved tolerability, with volume hitting 53.9 million shares.
Markets
Jul 7
↑